Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer

dc.contributor.author	Muñoz, Montserrat
dc.contributor.author	Estévez, Laura G.
dc.contributor.author	Álvarez, Isabel
dc.contributor.author	Fernández Pérez, Yolanda
dc.contributor.author	Margelí, Mireia
dc.contributor.author	Tusquets, Ángel
dc.contributor.author	Seguí, Miguel
dc.contributor.author	Lluch Bernal, Ana
dc.date.accessioned	2014-03-14T07:41:03Z
dc.date.available	2014-03-14T07:41:03Z
dc.date.issued	2008
dc.identifier.citation	Cancer Treatment Reviews, 34(8), p. 701-709 (2008); doi:10.1016/j.ctrv.2008.04.002
dc.identifier.issn	0305-7372
dc.identifier.uri	http://hdl.handle.net/10651/23720
dc.description.sponsorship	The authors acknowledge the support of GlaxoSmithKline Spain, which has supported the necessary meetings to evaluate and discuss all the data presented in this review, and Dr. Beatriz Gil-Alberdi from HealthCo SL for her assistance in the preparation of this manuscript
dc.format.extent	p. 701-709
dc.language.iso	eng
dc.relation.ispartof	Cancer Treatment Reviews
dc.rights	© 2008 Published by Elsevier Ltd
dc.source	WOS
dc.title	Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer
dc.type	journal article
dc.identifier.local	20140616
dc.identifier.doi	10.1016/j.ctrv.2008.04.002
dc.relation.publisherversion	http://dx.doi.org/10.1016/j.ctrv.2008.04.002

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.